| Gottlieb/1998 [23]
|
Retrospective cohort/two years |
41814 |
age 73.3±8.8, COPD subjects with previous history of myocardial infarction |
Mortality (0.60, 0.57–0.63) |
Unadjusted |
| Chen/2001 [24]
|
Retrospective cohort/one year |
10988 |
age<65, COPD or asthma subjects with previous history myocardial infarction |
Mortality (0.86, 0.73–1.00) |
Age, sex, comorbidities, CAD, cardiovascular drugs, physician speciality |
| Sin/2002 [25]
|
Retrospective cohort/median 21 months |
3834 |
age 79±8, COPD subjects with heart failure |
Mortality (0.78, 0.63–0.95) |
Age, sex, comorbidities, cardiovasculardrugs, physician speciality |
| taszewsky/2007 [27]
|
Retrospective cohort/median 23 months |
628 |
age 67±9, COPD subjects with heart failure |
Mortality (0.55, 0.37–0.82) |
Unadjusted |
| Au/2004 [26]
|
Retrospective cohort/two years |
1966 |
age 68.1±9.9, Veteran Affairs COPD subjects with hypertension |
Mortality (0.56, 0.16–1.93);ECOPD (0.65, 0.29–1.48) |
Comorbidity, age, history of COPD, bronchodilators, smoking, coronary artery disease, diabetes |
| Dransfield/2007 [29]
|
Retrospective cohort/− |
825 |
age 68±11, COPD subjects with acute Exacerbation |
Mortality (0.39, 0.14–0.99);ECOPD (0.46, 0.21–1.04) |
Age, CHD, CHF, liver disease, COPD exacerbations, malignancy, smoking, FEV1 |
| Van Gestel/2008 [28]
|
Retrospective cohort/median 5 years |
1205 |
COPD subjects with vascular disease |
Mortality (0.73, 0.60–0.88) |
Age, sex, hypertension, hypercho- lesterolemia, diabetes, renal func- tion, smoking, BMI, CAD, FEV1, cardiovascular drugs |
| Hawkins/2009 [30]
|
Retrospective cohort/median 25 months |
1258 |
age 68.1±9.9, COPD subjectswith myocardial infarction |
Mortality (0.74, 0.68–0.80) |
Unadjusted |
| Olenchock/2009 [31]
|
Retrospective cohort/two years |
12967 |
COPD or asthma subjects withacute coronary syn- dromes |
Mortality (0.52,0.45–0.60). |
Unadjusted |
| Rutten/2010 [32]
|
Retrospective cohort/7.2 years |
2230 |
Age 64.8±11.2, COPD primary care |
Mortality(0.68,0.56–0.83) for Cardio-selective BB,(0.82,0.61–1.10) fornon- selective BB; ECOPD(0.71, 0.60–0.83). |
Age, sex, diabetes, hypertension, CAD, CVD drugs, pulmonary drugs |
| Short/2011 [33]
|
Retrospective cohort/mean 4.35 years |
5977 |
Mean age 69.1 years, COPD primary care |
Mortality(0.78,0.67–0.92);ECOPD (0.39, 0.32–0.48). |
CAD and Respiratory disease, age, sex, diabetes, smoking, FEV1, cardiovascular drugs |
| tefan/2012 [35]
|
Retrospective cohort/two years |
35082 |
Age 73(65–80), COPD with heart failure, hypertension, ischemic heart disease |
In hospital mortality (0.88, 0.71–1.09); ECOPD(0.98, 0.77–1.24). |
Age, sex, underlying cardiovascular condition, ischaemic heart disease, congestive heart failure, drug, et al. |
| Ekström/2013 [37]
|
Prospective cohort/4 years |
2249 |
age>49, Severe COPD |
mortality (1.19, 1.04–1.37). |
Age, sex, body mass index, world heath organization performance status, resting blood gas tensions breathing air,comorbidities, and concomitant medication |
| geloni/2013 [34]
|
Retrospective cohort/median 36 months |
208 |
COPD after coronary artery bypass grafting |
Mortality (0.38, 0.20–0.71);ECOPD (1.02, 0.046–22.5). |
Unadjusted |
| Mentz/2013 [36]
|
Retrospective cohort/60–90 days |
725 |
age 73(63–80), COPD with heart failure |
Mortality (0.89, 0.59–1.35) |
Unadjusted |
